pta20210126023
Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)

Marinomed Biotech AG: Correction of a Release according to art. 135 section 2 BörseG from 25.01.2021

Korneuburg (pta023/26.01.2021/12:19 UTC+1) - Release of Announcement according to article 135 section 2 BörseG

Notification of Major Holdings

1. Issuer
Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria

2. Reason for notification
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation

Name: Acropora Beteiligungs GmbH
City and country of registered office: Vienna, Austria

4. Names of shareholders, if different from declarants (3)
Mohammed Al Sheikh
Abdulmohsen Al Sheikh

5. Date on which threshold was crossed or reached
21.01.2021

6. Total positions

  % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached 13,86 n/a 13,86 1,474,731
Position of previous notification 16,59 0,00 16,59

7. Notified details of the resulting situation

7.A: Voting rights attached to shares

ISIN code absolute direct (Sec 130 BörseG 2018) absolute indirect (Sec 133 BörseG 2018) in % direct (Sec 130 BörseG 2018) in % indirect (Sec 133 BörseG 2018)
ATMARINOMED6 0 204,410 0.00 13.86
Total:   204,410   13.86

7.B.1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
    Total: 0 0

7.B.2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
      Total: 0 0

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity.

No. Name Directly controlled by No. Shares held directly (%) Financial/other instruments held directly (%) Total of both (%)
1 Abdulmohsen Al Sheikh n/a n/a n/a
2 Mohammed Al Sheikh n/a n/a n/a
3 Acropora Beteiligungs GmbH 1,2 13,86 n/a 13,86

9. In case of proxy voting

Date of general meeting:
Voting rights after general meeting:

10. Other useful information

The participation notification is based on the fact that the threshold is not reached after the sale of 38,450 shares.

(end)

Emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Contact Person: Elisabeth Schön
Phone: +43226290300
E-Mail: elisabeth.schoen@marinomed.com
Website: www.marinomed.com
ISIN(s): ATMARINOMED6 (Share)
Stock Exchange(s): Vienna Stock Exchange (Official Trade)
|